PURINETONE 50MG TAB is a Schedule H drug. PURINETONE 50MG TAB is composed of: MERCAPTOPURINE (50.0 MG)
Tag: medicine for acute lymphoblastic leukemia
ONCOTRON 2MG INJ
ONCOTRON 2MG INJ is a Schedule H drug. ONCOTRON 2MG INJ is composed of: MITOXANTRONE (2.0 MG)
MITOZAN 20MG INJ
MITOZAN 20MG INJ is a Schedule H drug. MITOZAN 20MG INJ is composed of: MITOXANTRONE (20.0 MG)
MERCAPTO TAB
MERCAPTO TAB is a Schedule H drug. MERCAPTO TAB is composed of: MERCAPTOPURINE (50 MG)
6 MP 50MG TAB
6 MP 50MG TAB is a Schedule H drug. 6 MP 50MG TAB is composed of: MERCAPTOPURINE (50 MG)
PONATINIB
PONATINIB is a Schedule H drug.
PEGASPARGASE
PEGASPARGASE is a Schedule H drug.
MITOXANTRONE
MITOXANTRONE is a Schedule H drug.
MERCAPTOPURINE
MERCAPTOPURINE is a Schedule H drug.
BLINATUMOMAB
This medication is used to treat a certain type of cancer (acute lymphocytic leukemia-ALL). Acute lymphocytic leukemia is a cancer of the blood in which a particular kind of white blood cell is growing out of control. Blinatumomab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. Before you receive this medication, you may be given a corticosteroid medicine to help reduce infusion reactions. This medication comes in an injectable form to be given directly into the vein by continuous IV infusion for 4 weeks (28 days), followed by a 2 week break.